Pindolol, 5-Hydroxytryptamine, and Antidepressant Augmentation
- 1 November 1995
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 52 (11) , 969-971
Abstract
From JAMA Psychiatry — Pindolol, 5-Hydroxytryptamine, and Antidepressant AugmentationKeywords
This publication has 25 references indexed in Scilit:
- Biochemical Effects of Antidepressant AugmentationArchives of General Psychiatry, 1995
- Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake InhibitorsArchives of General Psychiatry, 1994
- Electrophysiological evidence for a large receptor reserve for inhibition of dorsal raphe neuronal firing by 5‐HT1A agonistsSynapse, 1993
- The novel 5‐HT1A receptor antagonist, SDZ 216–525, decreases 5‐HT release in rat hippocampus in vivoBritish Journal of Pharmacology, 1993
- Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: correlation with receptor bindingJournal of Neuroscience, 1992
- Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378European Journal of Pharmacology, 1990
- Subsensitivity of the 5-hydroxytryptamine1A (5-HT1A) receptor-mediated hypothermic response to ipsapirone in unipolar depressionLife Sciences, 1990
- Mixed agonist/antagonist properties of NAN-190 at 5-HT1A Receptors: Behavioural and in vivo brain microdialysis studiesLife Sciences, 1990
- Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: A comparative study with dorsal raphe neuronsNeuropharmacology, 1988
- Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptorsBrain Research, 1985